Shell SHEL Receives Upgrade to Buy After ARC Resources Transaction Germanys Trade Minister Visits Beijing as EU Diverges on China Overcapacity Policy Reid Hoffman Backs AI CancerResearch Startup Manas AI With 246 Million Taiwan Chip Stocks Rally as Nvidia Unveils 150 Billion Spending Plan Mainland Rivals Decline Dow Posts Record Closing High as Healthcare Consumer Stocks Rally AI Rally Pauses Spotify Gains Attention as Steve Cohen Portfolio Holding EDUC Q1 2026 Earnings Educational Development Corporation Reports Loss Amidst Unclear Revenue Picture CVM Q4 2024 Earnings Narrowing Losses with a 19 EPS Surprise Franklin Financial Services Corporation FRAF Q1 2026 Earnings Solid EPS Beat Lifts Sentiment Outlook Cautious Netcapital Inc NCPL Q1 2026 Earnings EPS Misses Estimates Stock Surges 47 MESO Q1 2026 Earnings EPS Miss Amid Ongoing Pipeline Progress Talos Energy Q1 2026 Earnings EPS Beat Drives Positive Market Sentiment Franklin Financial Services FRAF Gains Ground Testing Key Levels After 225 Rally IRSA Inversiones IRS Holds Steady at 1504 Key Support and Resistance Levels in Focus NewHold Investment Corp III NHIC Holds Steady Near Resistance SPAC Trading in Tight Range Tvardi Therapeutics TVRD Holds Steady Near Support Amid LowVolume Trading Alzamend Neuro ALZN Slides 174 as Stock Tests Key Support at 107 EU Dependence on China Deepens Across Solar Panels Rare Earths and Industrial Robots Array Digital Infrastructure Inc UZE Q1 2026 Earnings Earnings Per Share Surges Past Estimates FTAI Aviation Ltd FTAI Holds Steady Near Support After Modest Gain Vuzix VUZI Dips 155 as Augmented Reality Stock Hovers Above Key Support Western Asset Managed Municipals Fund MMU Rises 1 as Municipal Bonds Show Resilience Blackrock MuniHoldings California Quality Fund MUC Edges Higher as Municipal Bond Market Stabilizes Digital Currency X Technology Inc DCX Edges Lower Amid Cautious Market Sentiment Methode Electronics MEI Surges 383 as Shares Test Key Resistance Near 1225 Intercont Cayman Limited NCT Slides 926 Key Support Levels in Focus Zevra Therapeutics ZVRA Gains Momentum Breaks Above 10 Amid Bullish Volume